Roles & Affiliations: Ikhlas Khan serves as Director of the National Center for Natural Products Research (NCNPR), Distinguished Professor, and Research Professor of Pharmacognosy at the University of Mississippi's School of Pharmacy. He also leads the FDA Program and coordinates natural products research across multiple initiatives, including the Sino-US TCM Research Center and the Center for Research of Indian Systems of Medicine (CRISM). Education: B.Sc. Chemistry (1980) - Aligarh Muslim University, India M.Sc. Organic Chemistry (1982) - Aligarh Muslim University, India Ph.D. Pharmacy (1987) - Ludwig-Maximilians-Universität, Munich Postdoctoral Studies - Swiss Federal Institute of Technology (ETH), Zurich Research Focus: Dr. Khan specializes in natural products research with emphasis on: Phytomedicine: Standardization of herbal products via analytical fingerprinting, pesticide/herbicide residue analysis, and bioanalytical quality control. Drug Discovery: Isolation of bioactive natural products, development of analytical methods for phytochemical characterization, and chiral separation techniques. Metabolism Studies: Role of metabolism in drug/natural product activity, particularly in aminoquinoline antimalarials. His work bridges academia, industry, and regulatory bodies, shaping policies for botanical supplements. Key Contributions: Over 850 peer-reviewed publications and leadership in high-impact projects like the FDA Center of Excellence. His lab pioneered methods to combat herbal product adulteration and safety issues. Awards & Recognition: UM Distinguished Professor Award (2018) Wiley Award (AOAC International, 2018) Qihuang International Prize (2017) Honoris Causa Doctorate (University of Hamdard, 2012) Labs & Collaborations: Directs the NCNPR, a global leader in natural products research, and collaborates with institutions worldwide. His team develops technologies for herbal product authentication and drug metabolism studies.
Dr. Vakil Takhaveev is a Lecturer at ETH Zurich's Department of Health Sciences and Technology, within the Institute of Food, Nutrition and Health. His research focuses on DNA damage mechanisms, aging, cancer, and neurodegeneration, with particular emphasis on developing novel DNA-damage-sequencing methods like click-code-seq and TRABI-Seq . He investigates anticancer drug action (e.g., trabectedin), aging clocks using DNA oxidation profiling, and stress-induced carcinogenesis. His work integrates multi-omics approaches and advanced sequencing techniques. Research Directions: Novel DNA-Damage-Sequencing Methods: Developed click-code-seq and TRABI-Seq for genomic mapping of DNA lesions and repair dynamics. Anticancer Drug Action: Explored mechanisms of trabectedin and other chemotherapeutics, linking DNA repair vulnerabilities to therapy resistance. Aging Clocks: Created DNA oxidation-based biomarkers for biological aging using genome-wide profiling in human and mouse models. Stress-Induced Pathologies: Studies metabolic and DNA damage links to early tumorigenesis and neurodegeneration. Awards & Recognition: 2025 Public Award Winner in PIs of Tomorrow competition 2024 ETH Zurich Career Seed Award Best presentation awards (Swiss Chemical Society, American Chemical Society) Grants & Collaborations: Impetus grants for aging clock development Swiss Chemical Society and American Chemical Society fellowships Labs & Teams: Leads research on DNA damage and aging mechanisms at ETH Zurich, collaborating with international groups in oncology and toxicology.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Tim Q. Duong, Ph.D., is a Professor at Albert Einstein College of Medicine, affiliated with the Departments of Radiology, Biochemistry, Ophthalmology & Visual Sciences, and Neuroscience. His research focuses on medical imaging, MRI, image analysis, machine learning, and predictive modeling for studying diseases like COVID-19 , neurodegeneration (Alzheimer's, multiple sclerosis), brain injuries , and breast cancer . Develops AI-driven MRI techniques for early disease detection Investigates neuroplasticity in glaucoma and diabetic retinopathy Leads grants from NIH and National Eye Institute Research Trends : Recent publications emphasize AI integration in medical imaging, long-term effects of SARS-CoV-2, and advanced MRI applications for ocular and neurological disorders. Grants include multiple R01 awards for diabetic retinopathy and glaucoma studies. Training Opportunities : Actively recruits postdocs, research coordinators, and faculty. Offers research positions for graduate, medical, and high school students, including Regeneron Scholar programs. Labs & Teams : Leads the Duong Lab at Montefiore Medical Center, focusing on translational research for clinical imaging solutions.
Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.
Dr. Vivian Dayeh is an Associate Professor in the Department of Biology at the University of Waterloo, where she joined in 2004 as a full-time lecturer. Her roles include Teaching Fellow, Undergrad Advisor for Biomedical Science and Medical Physiology, and coordinator of the Biotech Technician Diploma program. Ph.D. Biology, University of Waterloo (2004) M.Sc. Biology, University of Waterloo (2001) B.Sc. Biology, University of Waterloo (1999) Dr. Dayeh specializes in cellular toxicology and in vitro methodology development , focusing on alternatives to whole-organism testing in aquatic environments. Her work explores toxicant effects on fish cells, particularly gill and intestinal epithelial systems, and employs protozoa as toxicity indicators. Recent research examines temperature and nutritional stress impacts on cell viability. Her publications from 2004-2025 demonstrate expertise in fish cell culture , cytotoxicity assays , and environmental contaminant testing , with applications in regulatory toxicology and industrial effluent analysis. 2024 Service Award, Society for In Vitro Biology 2021 Fellow Award, Society for In Vitro Biology Multiple Outstanding Performance Awards (2006-2020) Jack Carlson Teaching Excellence Awards (2006, 2018) Joseph F. Morgan Awards (2002, 2003) As an educator, Dr. Dayeh teaches core courses including Introductory Cell Biology , Human Anatomy , Human Physiology , Environmental Toxicology , and Animal Cell Biotechnology . She serves on the SIVB Board and facilitates instructional skills workshops.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models
Alessandra Arcuri is Full Professor of International Economic Law at the Department of Law and Markets, Erasmus School of Law, Erasmus University Rotterdam, and a member of the Erasmus Initiative on Inclusive Prosperity. Her academic leadership spans critical intersections of law, sustainability, and democratic governance within global economic frameworks. Her research interrogates the tensions between international economic law and planetary boundaries, focusing on how investment treaties constrain climate action through cases like Rockhopper v. Italy . She exposes how fossil fuel interests exploit legal mechanisms like the Energy Charter Treaty while analyzing glyphosate regulation failures and corporate influence on EU Green Deal implementation. Her work consistently challenges technocratic governance models that marginalize democratic participation in environmental decision-making. Recent scholarship reveals an intensified focus on supply-side climate policies, where investment law clashes with state efforts to phase out fossil fuels. She documents how tribunals prioritize investor protections over ecological imperatives, using Dutch river pollution cases to demonstrate states' international obligations to prevent toxic emissions. Her analysis of boundary-work in investment law reveals systemic exclusions of public interest perspectives. Scientific Awards: Jean Monnet Fellow (2011-12) Fernand Braudel Fellow (2021-22) Hauser Global Research Fellow (2003-04) Marie Curie Fellow (2001) Professor Arcuri supervises PhD candidates including Abdurrahman Erol, with whom she co-authored pivotal research on Dutch river degassing that directly influenced national policy banning toxic emissions from inland vessels. Her policy impact extends through commissioned reports for the Dutch Parliament, Ministry of Foreign Affairs, European Commission, and NGOs, translating academic rigor into tangible regulatory change. She actively bridges scholarly critique with public advocacy, as seen in open letters correcting ministerial misinterpretations of environmental law. As a core contributor to the Erasmus Initiative on Inclusive Prosperity, she collaborates across disciplines to reconfigure economic governance toward ecological sustainability and democratic accountability, challenging the fossil fuel economy through legal innovation and grassroots empowerment.
Dr. Stephanie Spahr is a Research Group Leader at the Leibniz Institute of Freshwater Ecology and Inland Fisheries (IGB) in Berlin, Germany, where she leads the Organic Contaminants research group within the Department of Ecohydrology and Biogeochemistry. Previously, she served as a Junior Research Group Leader at the University of Tübingen's Center for Applied Geoscience (2019-2021) and as a Postdoctoral Researcher at Stanford University's Department of Civil and Environmental Engineering (2016-2019). Dr. Spahr earned her PhD in Environmental Chemistry from the Swiss Federal Institute of Technology Lausanne (EPFL) and the Swiss Federal Institute of Aquatic Science and Technology (Eawag) in 2016. Her doctoral research focused on the formation of N-nitrosodimethylamine during water disinfection with chloramine. She completed her MSc in Geoecology at the University of Tübingen in 2012, with thesis work on carbon and nitrogen isotope analysis of benzotriazoles conducted at Eawag, and her BSc in Geoecology/Ecosystem Management at the same institution in 2010. Dr. Spahr's research focuses on trace organic contaminants in aquatic systems, with particular expertise in transformation processes of contaminants in natural and engineered systems, advanced oxidation processes for water treatment, urban blue-green infrastructure, and compound-specific isotope analysis. Her work bridges environmental chemistry, engineering, and ecology to address water quality challenges in urban and natural water systems. She employs advanced analytical techniques to track contaminant sources and transformation pathways, with a strong emphasis on practical applications for water treatment and environmental protection. Her recent publications demonstrate a strong focus on biochar-based water treatment technologies, particularly for stormwater management. She investigates how biochar amendments can remove trace organic contaminants from urban runoff, with recent work examining persulfate activation mechanisms, the role of chloride in reactive species formation, and the performance of engineered media filters under dynamic conditions. Her research also extends to understanding contaminant transport in rivers, the ecological impacts of pollutants, and developing analytical methods for environmental monitoring. The interdisciplinary nature of her work connects chemical processes with ecological outcomes. Outstanding Review Paper Award 2023 in Environmental Science: Water Research & Technology Selected for the Falling Walls Female Science Talents Intensive Track 2023 Selected mentee in the Leibniz Mentoring Programme 2022-2023 Best poster award (1st prize) at the Wasser 2022 of the Water Chemistry Society Selected fellow in the Postdoc Academy for Transformational Leadership 2020-2022 (Robert Bosch Stiftung) Selected fellow in the Athene Program for early female career researchers at the University of Tübingen, 2020-2021 As a Research Group Leader, Dr. Spahr supervises multiple research projects including 'POllution in UrbaN ponds, eco-evolutionary Dynamics, and Ecosystem Resilience (POUNDER)', 'Dynamic hyporheic zone', 'NYMPHE', and the 'Incident-related special investigation programme for the environmental disaster in the Oder River'. She serves on the Executive Board of the German Water Chemistry Society and heads its Expert Committee on 'Oxidative Processes'. Her collaborative work spans numerous institutions across Germany and internationally, addressing critical water quality challenges through interdisciplinary approaches. Dr. Spahr leads the Organic Contaminants research group at IGB Berlin, which focuses on understanding the fate and treatment of organic pollutants in water systems. Her team employs advanced analytical techniques including compound-specific isotope analysis to track contaminant sources and transformation pathways. The group collaborates extensively with other departments at IGB and with international partners on projects addressing urban water challenges and ecological impacts of pollution. Current research emphasizes innovative water treatment technologies, particularly biochar-based systems for stormwater management, and investigating the complex interactions between contaminants, aquatic ecosystems, and human activities.
Dr. Leon Barron is a Reader in Analytical & Environmental Sciences at the School of Public Health, Imperial College London. His expertise spans chemical contaminant analysis, wastewater epidemiology, and environmental forensics. He leads the Emerging Chemical Contaminants team within the Environmental Research Group, focusing on pharmaceuticals, PFAS, and illicit drugs. Education: BSc(Hons) in Analytical Science (2001), PhD in Analytical Chemistry (2005), and a Postgraduate Certificate in Academic Practice (2011). Previously held roles at King's College London as Lecturer (2009–2015) and Senior Lecturer (2015–2020). Research interests include trace environmental analysis (LC, GC, MS), chemical risk assessment, and wastewater-based epidemiology. Key projects include global drug use monitoring via sewage analysis and PFAS removal from drinking water. His work has produced over 100 peer-reviewed articles, with recent focus on PFAS accumulation, biochar filtration, and urban pollution source apportionment. Awards include Fellowships from Royal Society of Chemistry and Chartered Society of Forensic Sciences. Supervises PhD students on topics like pesticide exposure, opioid monitoring, and machine learning in ecotoxicology. Collaborates internationally via initiatives like the Sewage Analysis CORE Group and NIHR HPRU in Environmental Exposures.
Ada M. Fenick, MD, is a Professor of Pediatrics (General Pediatrics) at Yale School of Medicine. She holds multiple leadership roles including Associate Director for Pediatrics in the Biopsychosocial Approach to Health clerkship, Medical Director of School-Based Health Centers, and Medical Director of the Medical-Legal Partnership Project. Her clinical practice focuses on economically disadvantaged pediatric populations, emphasizing developmental aspects of child health and addressing toxic stress impacts. Education: BS in Biomedical Sciences (University of Michigan, 1990), MD (University of Michigan, 1993), Pediatric Residency (Weill-Cornell/NY Medical Center, 1996) Research: Centers on pediatric primary care innovations such as group well-child care models, medical-legal partnerships, and obesity prevention. Key themes include health equity, social determinants of health, and curriculum development. Her recent work emphasizes leveraging medical student experiences to improve curricula addressing social drivers of health. Over 20 peer-reviewed publications since 2020 focus on topics like electronic phenotyping algorithms for obesity screening and frameworks for group pediatric care implementation. Awards: Includes Howard A Pearson MD Teaching Award (2013) and multiple institutional recognitions for clinical excellence and innovation. She leads initiatives like the Yale Primary Care Pediatrics Curriculum and collaborates with community organizations to enhance access to early intervention services for vulnerable children. Her work integrates clinical care, education, and policy advocacy to promote holistic child health outcomes.
Dr Ysabel Gerrard is a Senior Lecturer in Digital Media and Society at the School of Sociological Studies, Politics and International Relations, University of Sheffield. Her work bridges digital sociology, gender studies, and platform governance, with a focus on youth experiences, content moderation, and ethical research practices. Education: BA (Hons), MA, PhD (University of Leeds) Research interests include: Young people’s social media experiences and content policies Digital identities, particularly gendered representations Feminist interventions in content moderation and algorithmic governance Ethical challenges in social media research Recent research examines the societal impact of social media design, reflected in her forthcoming book The Platform Generation and collaborations on Instagram’s mental health moderation, anonymous apps, and feminist critiques of platform labor. She contributes to policy debates via roles like Facebook’s Suicide and Self-Injury Advisory Board and ECREA leadership. Grants include: £39,985.50 for 'Creator labour: screen production cultures and transmedia intersectionality in Yorkshire' (2021-2022) £2,627 for 'Risky-by-design: making the digital world safer for children' (2021) £6,998 for 'Secrets on social media: anonymous apps and youth perspectives' (2019-2022) Teaching modules: Digital Identities, Introduction to Digital Methods. She supervises BA, MA, and PhD students working on topics like online dating, gaming toxicity, and influencer culture. Contact: Email: y.gerrard@sheffield.ac.uk Office: The Wave, 2 Whitham Road, Sheffield S10 2AH
Anja Boisen is a Professor and Head of the Drug Delivery and Sensing Section at the Department of Health Technology, Technical University of Denmark (DTU). Her research focuses on advanced drug delivery systems, sensing technologies, and nanotechnology applications in biomedical engineering. She leads a multidisciplinary team developing innovative devices such as microcontainers, microneedles, and lab-on-a-disc platforms for targeted drug delivery and diagnostics. Her work contributes to UN Sustainable Development Goals, particularly in improving health and reducing inequalities. Key research areas include surface-enhanced Raman spectroscopy (SERS), microfabrication for medical devices, and biomaterials for tissue engineering. She has supervised multiple PhD students, including projects on oral drug delivery systems, gastrointestinal retention devices, and energy-harvesting materials for biomedical applications. Boisen’s team has pioneered technologies like self-unfolding foils for oral delivery and smart drug delivery microparticles. Their innovations aim to enhance therapeutic efficacy while minimizing side effects. She has been recognized with the Sensor Division Outstanding Achievement Award (2022) for her contributions to sensor technology. Her lab actively collaborates internationally, advancing applications in cancer therapy, antibiotic monitoring, and gut microbiota research. Current projects explore high-throughput 3D tumor modeling, SERS-based diagnostics, and biodegradable materials for bone fixation.
Anna Salvati is an Associate Professor specializing in nanomedicine and drug delivery systems. Her research focuses on nanoparticle-cell interactions, biomolecular corona formation, and the physicochemical properties governing nanomaterial behavior in biological environments. Key research themes include cellular uptake mechanisms, toxicity of nanomaterials, and nanoparticle targeting strategies. Recent publications highlight her work on nanoparticle stability, membrane interactions, and environmental impacts of microplastics. Her studies integrate multiomics approaches, advanced imaging, and interlaboratory validation to address challenges in nanomedicine design and safety testing. Current projects explore the role of high-density lipoproteins in nanoparticle functionality and the modulation of drug release kinetics through material engineering.
